The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Matushevskaia E.V.

FGOU Institut povysheniia kvalifikatsii Federal'nogo mediko-biologicheskogo agentstva RF, Moskva

Svirshchevskaia E.V.

Institut bioorganicheskoĭ khimii im. M.M. Shemiakina i Iu.A. Ovchinnikova RAN, Moskva, 117997, Rossiĭskaia Federatsiia

Azelaic acid in dermatological and cosmetological practice

Authors:

Matushevskaia E.V., Svirshchevskaia E.V.

More about the authors

Read: 116954 times


To cite this article:

Matushevskaia EV, Svirshchevskaia EV. Azelaic acid in dermatological and cosmetological practice. Russian Journal of Clinical Dermatology and Venereology. 2014;12(5):11‑17. (In Russ.)

Recommended articles:
Clinical features of severe acne and gene­tic dete­rminants of therapeutic effi­cacy of systemic isotretinoin. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):30-37
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Influence of griseofulvin on inte­stinal microbiota in the treatment of microsporia in rural children. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):185-190
Effi­cacy of combined therapy of prurigo adultorum with application of temgicoluril anxiolytic. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):210-216
Damage of human skin barrier components in expo­sure of Demo­dex specimens. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):219-226
Combined treatment of patients with acute muscular tonic syndrome with dorsopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):70-77

References:

  1. Karimkhani C., Boyers L.N., Prescott L. et al. Global Burden of Skin Disease as Reflected in Cochrane Database of Systematic Reviews. JAMA Dermatol 2014.
  2. Thiboutot D., Gollnick H., Bettoli V. et al. Global Alliance to Improve Outcomes in Acne. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group. J Am Acad Dermatol 2009; 60: 5: Suppl: S1-S50.
  3. Zeichner J.A. Evaluating and treating the adult female patient with acne. J Drugs Dermatol 2013; 12: 12: 1416-1427.
  4. Chuang H.Y., Lee C.H. Female gender and acne disease are jointly and independently associated with the risk of major depression and suicide: a national population-based study. Biomed Res Int 2014.
  5. Adityan B., Thappa D.M. Profile of acne vulgaris-a hospital-based study from South India. Indian J Dermatol Venereol Leprol 2009; 75: 3: 272-278.
  6. Schnopp C., Mempel M. Acne vulgaris in children and adolescents. Minerva Pediatr 2011; 63: 4: 293-304.
  7. Robeva R., Assyov Y., Tomova A., Kumanov P. Acne vulgaris is associated with intensive pubertal development and altitude of residence-a cross-sectional population-based study on 6200 boys. Eur J Pediatr 2013; 172: 4: 465-471.
  8. Ulrich A., Hildebrandt U., Ulrich J. Acne inversa: Influence of associated factors in the extent of the disease and the result of surgery. Hautarzt 2014; 65: 7: 623-627.
  9. Navarini A.A., Simpson M.A., Weale M. et al. Genome-wide association study identifies three novel susceptibility loci for severe Acne vulgaris. Nat Commun 2014; 13: 5: 4020.
  10. McNairn A.J., Doucet Y., Demaude J. et al. TGF&Bgr; signaling regulates lipogenesis in human sebaceous glands cells. BMC Dermatol 2013; 23: 13: 2.
  11. Al-Shobaili H.A., Salem T.A., Alzolibani A.A. et al. Tumor necrosis factor-&agr;-308 G/A and interleukin 10-1082 A/G gene polymorphisms in patients with acne vulgaris. J Dermatol Sci 2012; 68: 1: 52-55.
  12. Antonioli L., Pacher P., Vizi E.S., Haskó G. CD39 and CD73 in immunity and inflammation. Trends Mol Med 2013; 19: 6: 355-367.
  13. Mizumoto N., Kumamoto T., Robson S.C. et al. CD39 is the dominant Langerhans cell-associated ecto-NTPDase: modulatory roles in inflammation and immune responsiveness. Nat Med 2002; 8: 4: 358-365.
  14. Berkey C.S., Rockett H.H., Willett W.C., Colditz G.A. Milk, dairy fat, dietary calcium, and weight gain. Arch Pediatr Adolesc Med 2005; 159: 543-550.
  15. Melnik B.C., John S.M., Plewig G. Acne: risk indicator for increased body mass index and insulin resistance. Acta Dermatol Venereol 2013; 93: 6: 644-649.
  16. Adebamowo C.A., Spiegelman D., Berkey C.S. et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol 2008; 58: 787-793.
  17. Shaheen B., Gonzalez M. A microbial aetiology of acne: what is the evidence? Br J Dermatol 2011; 165: 3: 474-485.
  18. Духанин А.С. Современные критерии рациональной фармакотерапии акне у женщин. Взгляд клинического фармаколога. Клин дерматол и венерол 2012; 2: 108-117.
  19. Khondker L., Khan S.I. Acne vulgaris related to androgens: a review. Mymensingh Med J 2014; 23: 1: 181-185.
  20. Zouboulis C.C., Rabe T. Hormonal antiandrogens in acne treatment. J Dtsch Dermatol Ges 2010; 8: Suppl 1: S60-S74.
  21. Yu J.S., Kim A.K. Effect of combination of taurine and azelaic acid on antimelanogenesis in murine melanoma cells. J Biomed Sci 2010; 17: Suppl 1: S45.
  22. Dreno B., Fischer T.C., Perosini E. et al. Expert opinion: effecacy of superficial peels in active acne management - what can we learn from the literature today? Evidence-based recommendations. J Eur Acad Dermatol Venereol 2011; 25: 6: 695-704.
  23. Stamatiadis D., Bulteau-Portois M.C., Mowszowicz I. Inhibition of 5 alpha-reductase activity in human skin by zinc and azelaic acid. Br J Dermatol 1988; 119: 5: 627-632.
  24. Passi S., Picardo M., De Luca C., Nazzaro-Porro M. Mechanism of azelaic acid action in acne. G Ital Dermatol Venereol 1989; 124: 10: 455-463.
  25. Worret W.I., Fluhr J.W. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid. J Dtsch Dermatol Ges 2006; 4: 4: 293-300.
  26. Wolf J.E. Jr. Maintenance therapy for acne vulgaris: the fine balance between efficacy, cutaneous tolerability, and adherence. Skinmed 2004; 3: 1: 23-26.
  27. Iraji F., Sadeghinia A., Shahmoradi Z. et al. Efficacy of topical azelaic acid gel in the treatment of mild-moderate acne vulgaris. Indian J Dermatol Venereol Leprol 2007; 73: 2: 94-96.
  28. Gollnick H.P., Graupe K., Zaumseil R.P. Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies. J Dtsch Dermatol Ges 2004; 2: 10: 841-847.
  29. Stinco G., Bragadin G., Trotter D., Pillon B., Patrone P. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne. J Eur Acad Dermatol Venereol 2007; 21: 3: 320-325.
  30. Thiboutot D., Thieroff-Ekerdt R., Graupe K. Efficacy and safety of azelaic acid (15%) gel as a new treatment for papulopustular rosacea: results from two vehicle-controlled, randomized phase III studies. J Am Acad Dermatol 2003; 48: 6: 836-845.
  31. Gamble R., Dunn J., Dawson A., Petersen B., McLaughlin L., Small A., Kindle S., Dellavalle R.P. Topical antimicrobial treatment of acne vulgaris: an evidence-based review. Am J Clin Dermatol 2012; 13: 3: 141-152.
  32. European Evidence-based (S3) Guidelines for the Treatment of Acne. JEADV 2012; 26: Suppl 1: 1-29.
  33. Gerlinger C., Sta¨dtler G., Go¨tzelmann R. et al. A noninferiority margin for acne lesion counts. Drug Inform J 2008; 42: 607-615.
  34. Webster G. Combination azelaic acid therapy for acne vulgaris. J Am Acad Dermatol 2000; 43: 2: Pt 3: S47-S50.
  35. Thiboutot D.M., Fleischer A.B., Del Rosso J.Q., Rich P. A multicenter study of topical azelaic acid 15% gel in combination with oral doxycycline as initial therapy and azelaic acid 15% gel as maintenance monotherapy. J Drugs Dermatol 2009; 8: 7: 639-648.
  36. Del Rosso J.Q., Bruce S., Jarratt M., Menter A., Staedtler G. Efficacy of topical azelaic acid (AzA) gel 15% plus oral doxycycline 40 mg versus metronidazole gel 1% plus oral doxycycline 40 mg in mild-to-moderate papulopustular rosacea. J Drugs Dermatol 2010; 9: 6: 607-613.
  37. Pazoki-Toroudi H., Nilforoushzadeh M.A., Ajami M. et al. Combination of azelaic acid 5% and clindamycin 2% for the treatment of acne vulgaris. Cutan Occul Toxicol 2011; 30: 4: 286-291.
  38. Pazoki-Toroudi H., Nassiri-Kashani M., Tabatabaie H. et al. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris. J Dermatolog Treat 2010; 21: 3: 212-216.
  39. Горячкина М.В., Белоусова Т.А. Современенные представления о патогенезе, клинике и терапии акне у женщин. РМЖ 2012; 22: 1153-1157.
  40. Wójcik A., Kubiak M., Rotsztejn H. Influence of azelaic and mandelic acid peels on sebum secretion in ageing women. Postepy Dermatol Alergol 2013; 30: 3: 140-145.
  41. Сайбель А.В. Скинорен и пилинги в лечении акне. Вестн эстет мед 2012; 11: 2: 104-106.
  42. Del Rosso J.Q. The use of moisturizers as an integral component of topical therapy for rosacea: clinical results based on the Assessment of Skin Characteristics Study. Cutis 2009; 84: 2: 72-76.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.